Long-Term corticosterone treatment induced lobe-specific pathology in mouse prostate

Prostate

Volumn 71, Issue 3, 2011, Pages 289-297

  Simanainen, Ulla ^a   Lampinen, Anita ^a,b   Henneicke, Holger ^a   Brennan, Tara C ^a   Heinevetter, Uta ^a   Harwood, D Tim ^a   McNamara, Keely ^a   Herrmann, Markus ^a   Seibel, Markus J ^a   Handelsman, David J ^a   Zhou, Hong ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

corticosterone; glucocorticoid receptor; mouse; prostate; prostate pathology

Indexed keywords

CORTICOSTERONE; FIBROBLAST GROWTH FACTOR 10; GLUCOCORTICOID RECEPTOR; PLACEBO; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BASAL CELL; CONTROLLED STUDY; HISTOLOGY; LONG TERM CARE; MALE; MITOGENESIS; MOUSE; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; STEADY STATE; TREATMENT DURATION;

ANIMALS; APOPTOSIS; BODY WEIGHT; CELL PROLIFERATION; CORTICOSTERONE; GENE EXPRESSION; MALE; MICE; ORGAN SIZE; PROSTATE; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID;

EID: 78951490732     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21242     Document Type: Article

References (56)

1. Yemelyanov A, Czwornog J, Chebotaev D, Karseladze A, Kulevitch E, Yang X, Budunova I,. Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene 2007; 26 (13): 1885-1896.
2. Mohler JL, Chen Y, Hamil K, Hall SH, Cidlowski JA, Wilson EM, French FS, Sar M,. Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Clin Cancer Res 1996; 2 (5): 889-895.
3. Fakih M, Johnson CS, Trump DL,. Glucocorticoids and treatment of prostate cancer: A preclinical and clinical review. Urology 2002; 60 (4): 553-561.
4. Almeida SA, Petenusci SO, Anselmo-Franci JA, Rosa-e-Silva AA, Lamano-Carvalho TL,. Decreased spermatogenic and androgenic testicular functions in adult rats submitted to immobilization-induced stress from prepuberty. Braz J Med Biol Res 1998; 31 (11): 1443-1448.
5. Lerman SA, Miller GK, Bohlman K, Albaladejo V, Leonard JF, Devas V, Clark RL,. Effects of corticosterone on reproduction in male Sprague-Dawley rats. Reprod Toxicol 1997; 11 (6): 799-805.
6. Harvey PW, Er J, Fernandes C, Rush KC, Major IR, Cockburn A,. Corticosterone does not cause testicular toxicopathology in the rat: Relevance to methylxanthines, ACTH and stress. Hum Exp Toxicol 1992; 11 (6): 505-509.
7. Herrmann M, Henneicke H, Street J, Modzelewski J, Kalak R, Buttgereit F, Dunstan CR, Zhou H, Seibel MJ,. The challenge of continuous exogenous glucocorticoid administration in mice. Steroids 2009; 74 (2): 245-249.
8. Simanainen U, McNamara K, Gao YR, Handelsman DJ,. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation. Am J Physiol Endocrinol Metab 2009; 296 (6): E1335-E1343.
9. Simanainen U, Allan CM, Lim P, McPherson S, Jimenez M, Zajac JD, Davey RA, Handelsman DJ,. Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function. Endocrinology 2007; 148 (5): 2264-2272.
10. Harwood DT, Handelsman DJ,. Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta 2009; 409 (1-2): 78-84.
11. McNamara KM, Harwood DT, Simanainen U, Walters KA, Jimenez M, Handelsman DJ,. Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol 2010. DOI: 10.1016/j.jsbmb.2010.02.001.
12. Medh RD, Thompson EB,. Hormonal regulation of physiological cell turnover and apoptosis. Cell Tissue Res 2000; 301 (1): 101-124.
13. Cunha GR, Ricke W, Thomson A, Marker PC, Risbridger G, Hayward SW, Wang YZ, Donjacour AA, Kurita T,. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 2004; 92 (4): 221-236 [Epub December 2004].
14. Rennie PS, Bowden JF, Bruchovsky N, Cheng H,. The relationship between inhibition of plasminogen-activator activity and prostatic involution. Biochem J 1988; 252 (3): 759-764.
15. Rennie PS, Bowden JF, Freeman SN, Bruchovsky N, Cheng H, Lubahn DB, Wilson EM, French FS, Main L,. Cortisol alters gene expression during involution of the rat ventral prostate. Mol Endocrinol 1989; 3 (4): 703-708.
16. Marker PC, Donjacour AA, Dahiya R, Cunha GR,. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 2003; 253: 165-174.
17. Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, Shigemura K, Miyagi T, Seo S, Shi C, Molitierno J, Elmore J, Anderson C, Isotani S, Edlund M, Hsieh CL, Wang R, Shehata B, Zhau HE,. Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer 2006; 5 (2): 162-170.
18. Thomson AA, Cunha GR,. Prostatic growth and development are regulated by FGF10. Development 1999; 126 (16): 3693-3701.
19. Memarzadeh S, Xin L, Mulholland DJ, Mansukhani A, Wu H, Teitell MA, Witte ON,. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 2007; 12 (6): 572-585.
20. Valta MP, Tuomela J, Vuorikoski H, Loponen N, Vaananen RM, Pettersson K, Vaananen HK, Harkonen PL,. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer. J Cell Biochem 2009; 107 (4): 769-784.
21. Mattila MM, Harkonen PL,. Role of fibroblast growth factor 8 in growth and progression of hormonal cancer. Cytokine Growth Factor Rev 2007; 18 (3-4): 257-266.
22. Konno-Takahashi N, Takeuchi T, Nishimatsu H, Kamijo T, Tomita K, Schalken JA, Teshima S, Kitamura T,. Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobe. Eur Urol 2004; 46 (1): 126-132.
23. Giri D, Ropiquet F, Ittmann M,. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 1999; 5 (5): 1063-1071.
24. Chaffer CL, Dopheide B, Savagner P, Thompson EW, Williams ED,. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. Differentiation 2007; 75 (9): 831-842.
25. Yamanishi H, Nonomura N, Tanaka A, Nishizawa Y, Terada N, Matsumoto K, Sato B,. Proliferation of Shionogi carcinoma 115 cells by glucocorticoid-induced autocrine heparin-binding growth factor(s) in serum-free medium. Cancer Res 1991; 51 (11): 3006-3010.
26. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A,. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999; 20 (4): 501-534.
27. te Pas MF, de Jong PR, Verburg FJ,. Glucocorticoid inhibition of C2C12 proliferation rate and differentiation capacity in relation to mRNA levels of the MRF gene family. Mol Biol Rep 2000; 27 (2): 87-98.
28. Lin TM, Ko K, Moore RW, Simanainen U, Oberley TD, Peterson RE,. Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicol Sci 2002; 68 (2): 479-487.
29. Risbridger GP, Wang H, Frydenberg M, Cunha G,. The metaplastic effects of estrogen on mouse prostate epithelium: Proliferation of cells with basal cell phenotype. Endocrinology 2001; 142 (6): 2443-2450.
30. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y,. The endocrinology and developmental biology of the prostate. Endocr Rev 1987; 8 (3): 338-362.
31. Prins GS,. Differential regulation of androgen receptors in the separate rat prostate lobes: Androgen independent expression in the lateral lobe. J Steroid Biochem 1989; 33 (3): 319-326.
32. Banerjee PP, Banerjee S, Tilly KI, Tilly JL, Brown TR, Zirkin BR,. Lobe-specific apoptotic cell death in rat prostate after androgen ablation by castration. Endocrinology 1995; 136 (10): 4368-4376.
33. Monder C, Sakai RR, Miroff Y, Blanchard DC, Blanchard RJ,. Reciprocal changes in plasma corticosterone and testosterone in stressed male rats maintained in a visible burrow system: Evidence for a mediating role of testicular 11 beta-hydroxysteroid dehydrogenase. Endocrinology 1994; 134 (3): 1193-1198.
34. Mohler JL,. A role for the androgen-receptor in clinically localized and advanced prostate cancer. Best Pract Res Clin Endocrinol Metab 2008; 22 (2): 357-372.
35. Sjogren J, Weck M, Nilsson A, Ottosson M, Bjorntorp P,. Glucocorticoid hormone binding to rat adipocytes. Biochim Biophys Acta 1994; 1224 (1): 17-21.
36. Snochowski M, Dahlberg E, Gustafsson JA,. Characterization and quantification of the androgen and glucocorticoid receptors in cytosol from rat skeletal muscle. Eur J Biochem 1980; 111 (2): 603-616.
37. Dahlberg E, Snochowski M, Gustafsson JA,. Androgen and glucocorticoid receptors in rat skeletal muscle. Acta Chem Scand B 1980; 34 (2): 141-143.
38. Chang CS, Kokontis J, Chang CT, Liao SS,. Cloning and sequence analysis of the rat ventral prostate glucocorticoid receptor cDNA. Nucleic Acids Res 1987; 15 (22): 9603.
39. Dahlberg E, Snochowski M, Gustafsson JA,. Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol. Endocrinology 1981; 108 (4): 1431-1440.
40. Syms AJ, Nag A, Norris JS, Smith RG,. Glucocorticoid effects on growth, and androgen receptor concentrations in DDT1MF-2 cell lines. J Steroid Biochem 1987; 28 (2): 109-116.
41. Smith RG, Syms AJ, Norris JS,. Differential effects of androgens and glucocorticoids on regulation of androgen receptor concentrations and cell growth. J Steroid Biochem 1984; 20 (1): 277-281.
42. Mayer M, Shafrir E, Kaiser N, Milholland RJ, Rosen F,. Interaction of glucocorticoid hormones with rat skeletal muscle: Catabolic effects and hormone binding. Metabolism 1976; 25 (2): 157-167.
43. Nordeen SK, Suh BJ, Kuhnel B, Hutchison CA III., Structural determinants of a glucocorticoid receptor recognition element. Mol Endocrinol 1990; 4 (12): 1866-1873.
44. Roche PJ, Hoare SA, Parker MG,. A consensus DNA-binding site for the androgen receptor. Mol Endocrinol 1992; 6 (12): 2229-2235.
45. Ham J, Thomson A, Needham M, Webb P, Parker M,. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res 1988; 16 (12): 5263-5276.
46. Claessens F, Celis L, Peeters B, Heyns W, Verhoeven G, Rombauts W,. Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein. Biochem Biophys Res Commun 1989; 164 (2): 833-840.
47. Cleutjens CB, Steketee K, van Eekelen CC, van der Korput JA, Brinkmann AO, Trapman J,. Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells. Endocrinology 1997; 138 (12): 5293-5300.
48. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS,. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 1996; 10 (2): 119-131.
49. Schauwaers K, De Gendt K, Saunders PT, Atanassova N, Haelens A, Callewaert L, Moehren U, Swinnen JV, Verhoeven G, Verrijdt G, Claessens F,. Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model. Proc Natl Acad Sci USA 2007; 104 (12): 4961-4966.
50. Verrijdt G, Tanner T, Moehren U, Callewaert L, Haelens A, Claessens F,. The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response. Biochem Soc Trans 2006; 34 (Pt 6): 1089-1094.
51. Pollard M, Snyder DL, Luckert PH,. Dihydrotestosterone does not induce prostate adenocarcinoma in L-W rats. Prostate 1987; 10 (4): 325-331.
52. Notini AJ, Davey RA, McManus JF, Bate KL, Zajac JD,. Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model. J Mol Endocrinol 2005; 35 (3): 547-555.
53. Badrinarayanan R, Rengarajan S, Nithya P, Balasubramanian K,. Corticosterone impairs the mRNA expression and activity of 3beta- and 17beta-hydroxysteroid dehydrogenases in adult rat Leydig cells. Biochem Cell Biol 2006; 84 (5): 745-754.
54. Suter DE, Schwartz NB,. Effects of glucocorticoids on responsiveness of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone by male rat pituitary cells in vitro. Endocrinology 1985; 117 (3): 855-859.
55. Hardy MP, Gao HB, Dong Q, Ge R, Wang Q, Chai WR, Feng X, Sottas C,. Stress hormone and male reproductive function. Cell Tissue Res 2005; 322 (1): 147-153.
56. Balasubramanian K, Aruldhas MM, Govindarajulu P,. Effect of corticosterone on rat epididymal lipids. J Androl 1987; 8 (2): 69-73.